NO20055137L - Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer - Google Patents

Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Info

Publication number: NO20055137L
Authority: NO; Norway
Prior art keywords: macrolide; treatment; local anesthetic; combination; skin diseases
Prior art date: 2003-04-04

Application number

NO20055137A

Other languages

English (en)

Norwegian (no)

Other versions

NO20055137D0 (no

Inventor

Maximillan Grassberger

Stefan Hirsch

Nabila Sekkat

Carl-Martin Weiss

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-04

Filing date

2005-11-02

Publication date

2006-01-04

2005-11-02 Application filed by Novartis Ag filed Critical Novartis Ag

2005-11-02 Publication of NO20055137D0 publication Critical patent/NO20055137D0/no

2006-01-04 Publication of NO20055137L publication Critical patent/NO20055137L/no

Links

239000003589 local anesthetic agent Substances 0.000 title abstract 2
239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
208000017520 skin disease Diseases 0.000 title 1
208000003251 Pruritus Diseases 0.000 abstract 2
208000002874 Acne Vulgaris Diseases 0.000 abstract 1
206010003645 Atopy Diseases 0.000 abstract 1
201000004624 Dermatitis Diseases 0.000 abstract 1
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
206010000496 acne Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000002955 immunomodulating agent Substances 0.000 abstract 1
230000002584 immunomodulator Effects 0.000 abstract 1
229940121354 immunomodulator Drugs 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
229940125721 immunosuppressive agent Drugs 0.000 abstract 1
230000007803 itching Effects 0.000 abstract 1
229960004194 lidocaine Drugs 0.000 abstract 1
229960001807 prilocaine Drugs 0.000 abstract 1
MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 abstract 1
201000004700 rosacea Diseases 0.000 abstract 1
239000011885 synergistic combination Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20055137A 2003-04-04 2005-11-02 Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer NO20055137L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0307869.8A GB0307869D0 (en)	2003-04-04	2003-04-04	Pharmaceutical composition
PCT/EP2004/003515 WO2004087144A1 (en)	2003-04-04	2004-04-02	Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases

Publications (2)

Publication Number	Publication Date
NO20055137D0 NO20055137D0 (no)	2005-11-02
NO20055137L true NO20055137L (no)	2006-01-04

Family

ID=9956231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055137A NO20055137L (no)	2003-04-04	2005-11-02	Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Country Status (13)

Country	Link
US (1)	US20060110448A1 (sr)
EP (1)	EP1613317A1 (sr)
JP (1)	JP2006522061A (sr)
CN (1)	CN1771036A (sr)
AU (1)	AU2004226823A1 (sr)
BR (1)	BRPI0409207A (sr)
CA (1)	CA2521261A1 (sr)
GB (1)	GB0307869D0 (sr)
IS (1)	IS8106A (sr)
MX (1)	MXPA05010709A (sr)
NO (1)	NO20055137L (sr)
RS (1)	RS20050752A (sr)
WO (1)	WO2004087144A1 (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9687455B2 (en)	2014-08-14	2017-06-27	John Daniel Dobak	Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en)	2015-02-27	2016-05-31	John Daniel Dobak, III	Reduction of adipose tissue
KR102141441B1 (ko) *	2018-06-28	2020-08-05	이환석	무출혈 무통필름
CN108853312B (zh) *	2018-09-25	2021-04-16	陕西天宇制药有限公司	聚桂醇外用凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB766245A (en) *	1954-09-03	1957-01-16	Lilly Co Eli	Therapeutic preparations containing erythromycin
HU194493B (en) *	1985-11-27	1988-02-29	Chinoin Gyogyszer Es Vegyeszet	Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
JPH08133979A (ja) *	1994-09-16	1996-05-28	Sando Yakuhin Kk	局所適用薬剤組成物
CN100335063C (zh) *	1994-10-26	2007-09-05	诺瓦蒂斯有限公司	药物组合物
CN1158258A (zh) *	1996-12-11	1997-09-03	李志辉	秦云创伤外用药
GB9723669D0 (en) *	1997-11-07	1998-01-07	Univ Aberdeen	Skin penetration enhancing components
US6120792A (en) *	1998-04-29	2000-09-19	Juni; Jack E.	Medicated skin patch and method for its use
JP2001288086A (ja) *	1999-07-21	2001-10-16	Shoei:Kk	皮膚疾患の治療用又は予防用外用剤
JP2001288085A (ja) *	1999-07-21	2001-10-16	Shoei:Kk	乾癬の治療用又は予防用外用剤
GB0003932D0 (en) *	2000-02-18	2000-04-12	Novartis Ag	Pharmaceutical compositions
WO2002062353A1 (en) *	2001-02-05	2002-08-15	Marie Madeline Wharton	Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof
RU2195279C1 (ru) *	2001-07-10	2002-12-27	Тульский государственный университет	Способ лечения отморожений
CN1189193C (zh) *	2001-09-10	2005-02-16	黄家伶	烧伤药膏
CN1197576C (zh) *	2002-08-30	2005-04-20	孙万一	治疗性病疣的药物及其制备方法

2003
- 2003-04-04 GB GBGB0307869.8A patent/GB0307869D0/en not_active Ceased
2004
- 2004-02-04 US US10/550,360 patent/US20060110448A1/en not_active Abandoned
- 2004-04-02 WO PCT/EP2004/003515 patent/WO2004087144A1/en not_active Ceased
- 2004-04-02 MX MXPA05010709A patent/MXPA05010709A/es not_active Application Discontinuation
- 2004-04-02 BR BRPI0409207-4A patent/BRPI0409207A/pt not_active IP Right Cessation
- 2004-04-02 RS YUP-2005/0752A patent/RS20050752A/sr unknown
- 2004-04-02 AU AU2004226823A patent/AU2004226823A1/en not_active Abandoned
- 2004-04-02 EP EP04725354A patent/EP1613317A1/en not_active Withdrawn
- 2004-04-02 CA CA002521261A patent/CA2521261A1/en not_active Abandoned
- 2004-04-02 CN CNA2004800092493A patent/CN1771036A/zh active Pending
- 2004-04-02 JP JP2006504968A patent/JP2006522061A/ja active Pending
2005
- 2005-10-31 IS IS8106A patent/IS8106A/is unknown
- 2005-11-02 NO NO20055137A patent/NO20055137L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2521261A1 (en)	2004-10-14
CN1771036A (zh)	2006-05-10
IS8106A (is)	2005-10-31
JP2006522061A (ja)	2006-09-28
AU2004226823A1 (en)	2004-10-14
US20060110448A1 (en)	2006-05-25
RS20050752A (sr)	2007-11-15
GB0307869D0 (en)	2003-05-14
NO20055137D0 (no)	2005-11-02
MXPA05010709A (es)	2005-12-12
BRPI0409207A (pt)	2006-03-28
WO2004087144A1 (en)	2004-10-14
EP1613317A1 (en)	2006-01-11

Legal Events

Date	Code	Title	Description
2008-11-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY1121135T1 (el)	2019-12-11	Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
NO20054988L (no)	2005-12-23	Preparater og metoder for behandling av cancer
WO2009061916A3 (en)	2009-07-16	Benzodiazepinone compounds useful in the treatment of skin conditions
NO20081041L (no)	2008-05-22	PPar aktive forbindelser
NO20073068L (no)	2007-06-15	Stereoisomere anrikete 3-aminokarbonylbisykloheptenpyrimidindiaminforindelser og deres anvendelse
WO2006120682A3 (en)	2007-01-25	Compositions and methods for treating hyperproliferative epidermal diseases
WO2001078706A3 (en)	2002-03-28	Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
AR054094A1 (es)	2007-06-06	Tratamientos de cancer
WO2005079143A3 (en)	2006-03-09	Topical formulations for the treatment of skin conditions
WO2006015263A3 (en)	2006-07-27	Lonidamine analogs
DK1392131T3 (da)	2008-11-17	Huddiætfoder til kæledyr
NO20055136L (no)	2006-01-04	Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer
Simonsson	2005	Beneficial effects of cytogenetic and molecular response on long-term outcome in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib (IM): update from the IRIS study.
WO2007065289A3 (en)	2007-08-02	4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
WO2008058210A3 (en)	2008-10-09	Local administration of gallium compositions to treat pain
GEP20135900B (en)	2013-08-12	Emollient composition
NO20055137L (no)	2006-01-04	Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer
NO20092134L (no)	2009-09-18	Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser
DE602006016231D1 (de)	2010-09-30	9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl-y-aminopropyl-azalide mit antimalaria-aktivität
BR0315195A (pt)	2005-08-23	Composições farmacêuticas e usos das composições
BRPI0518700B8 (pt)	2021-05-25	combinação contendo vegf-trap, 5-fluorouracila e ácido folínico
AR042476A1 (es)	2005-06-22	Composiciones farmaceuticas que comprenden una asociacion de calcitriol y de un propionato de clobetasol
DK1596879T3 (da)	2011-04-11	Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
NO20055170L (no)	2006-01-04	Organiske forbindelser
EA200702026A1 (ru)	2008-04-28	Лечение или предупреждение зуда